CVS Health will acquire Oak Street Health in an all-cash transaction at $39 per share, which represents an enterprise value of approximately $10.6 billion.
Clinical Trial Services will recruit patients at 39 proact 1 (REGEN-006) clinical sites, using a machine learning model to identify patient populations that align with trial inclusion/exclusion criteria.
David Joyner will rejoin the company as executive vice president and president of pharmacy services, while Amy Bricker has been named executive vice president and chief product officer – consumer.